Atridox, utilized as part of the soft tissue management program at Dr. Z's office, is a subgingival controlled-release product and accepted by the ADA.  The anti-microbial agent is deposited into the deep pockets caused by gum disease, where its anti-microbial activity is released over 7 day period to reduce the number of periodontal pathogens found in the diseased pocket.  Used in conjunction with ultrasonic scaling aids in reducing pocket depth and gum bleeding upon probing, thereby improving overall gum health of the patient.

To learn more, click the link (www.arestin.com)